Difference between THC Oil, Cannabis oil, CBD oil, marijuana oil

Can we lawfully buy and consume marijuana in France today? Yes and no. Yes, because the state has actually unwinded its guidelines on CBD, including through the Minister of Health. And no, at the same time, because only products including cannabidiol (CBD), an active substance that does not have the psychoactive results attributed to THC, are thought about legal. Let us take stock of what is legal and what is not with regard to marijuana and one world CBD.

CBD is legal in France, but THC is not

Cannabis must not be puzzled with cannabidiol. Specifically since the second is legal in certain kinds in France … While the other is not! Due to the fact that cannabidiol (known by the acronym CBD) is just one of the many active compounds from the hemp plant, which does not have the psychoactive results of its cousin THC – the one that makes you “stone”.

Simply put, what is normally called “marijuana”, which consists of high concentrations of THC (tetrahydrocannabinol) is still thought about a narcotic product. And for that reason illegal in France as in many countries on earth. On the other hand, marijuana which gives pride of place to the cannabinoid known as cannabidiol, it is legal as long as its THC levels do not go beyond 0.2%.

However, the legislation remains vague in France on this subject. Presently, there is no law that makes it clear whether CBD stream is legal or not. Concretely, it is authorized for sale in the form of E-liquid, to be used in a smokeless cigarette. However it is likewise found in other kinds (including oil or paste), without its purchase and usage being reprehensible … To try to make it easy, let’s say that CBD is not forbidden by French law, unlike THC


Although CBD and THC are identical, they are really different. These are the best known of the 500 cannabinoids found in hemp. And each has its specific results. THC is especially known for its psychoactive residential or commercial properties: it triggers a modification in the state of awareness by acting directly on the brain. By taking in marijuana rich in THC, we “hover”: well-being, euphoria, relaxation … But likewise red eyes, dilated students and, in some cases, anxiety or even paranoia.

CBD has nothing to do with it. It is not euphoric. It does not trigger anxiety or anxiety attacks. On the contrary: cannabidiol remains in the process of making its method by virtue of its advantageous restorative results. CBD assists eliminate pain and inflammation, reduce anxiety, alleviate the suffering of victims of anxiety attacks and depression, and even treat certain diseases (such as epilepsy or Alzheimer’s). In addition, it has a very low toxicity and presents (nearly) no addicting threat, even if the lack of scientific studies lowers these characteristics to simple hypotheses.

Legalization of CBD in France: should we go further?

Definitely, the legal development concerning CBD is positive, but whatever remains to be done. The health ministry wishes to beware, and the federal government’s position on the matter looks like a balancing act. At the same time, the National Medicines Agency has actually clearly spoken out. We for that reason take care of the goat and the cabbage so as not to get too included, while the vaporized cannabidiol has actually been available in France for a couple of years currently, benefiting from the legal ambiguity that persists.

Beyond the 0.2% THC threshold authorized in marketed products, it must be borne in mind that only the liquid form of CBD (planned for electric cigarettes) is actually legal. The purchase and usage of resin or cigarette smoking herb is for that reason not managed, particularly since the THC level is often greater (around 15%). In addition, only making use of seeds and fibers is authorized in France. However what about CBD oil, which enables you to enjoy the advantages of the substance without exposing your lungs to potentially damaging smoke? What about CBD paste? On these topics, there is radio silence.

In addition, CBD is thought about a “dietary supplement”, which forbids providing it as a medication. And make it an enlightened ad for users and patients. Too bad, because, in the meantime, many prospective recipients are not benefiting from it. It is for that reason essential to go further and clarify things: more than a question of customer welfare, it refers public health.

Scroll to top